A new and efficient method for the synthesis of rocuronium bromide
查看参考文献36篇
文摘
|
Rocuronium bromide has been used as an aminosteroid non-depolarizing neuromuscular blocker and muscle relaxant. In this work, a new and efficient route for preparing a key intermediate 2β-(4- morpholinyl)-16β-(1-pyrrolidinyl)-5α-androstan-3α,17β-diol (6)was developed through a ring-opening of epoxide followed by introducing and pyrrolidine. Compound 6 can easily provide rocuronium bromide and the overall yield of compound 6 in 5 steps increased to 57.8%, which was higher than currently reported methods. Extraordinarily, this method would avoid the generation of disubstituted impurities E and F which are difficult to remove. |
来源
|
Chinese Chemical Letters
,2017,28(2):487-492 【核心库】
|
DOI
|
10.1016/j.cclet.2016.10.026
|
关键词
|
Rocuronium bromide
;
2α,3α-Epoxy steroid derivative
;
NMBAs
;
Fe-mediated
;
New route
|
地址
|
1.
School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang, 110016
2.
West China School of Pharmacy, Sichuan University, Key Laboratory of Drug Targeting and Drug Delivery Systems of Ministry of Education, Chengdu, 610041
|
语种
|
英文 |
文献类型
|
研究性论文 |
ISSN
|
1001-8417 |
学科
|
化学工业 |
基金
|
support from the National Natural Science Foundation of China
|
文献收藏号
|
CSCD:5934409
|
参考文献 共
36
共2页
|
1.
Rees D C. Drugs in anesthetic practice.
Annu. Rep. Med. Chem,1996,31:41-50
|
CSCD被引
1
次
|
|
|
|
2.
Tuba Z. Synthesis and structure-activity relationships of neuromuscular blocking agents.
Curr. Med. Chem,2002,9:1507-1536
|
CSCD被引
3
次
|
|
|
|
3.
Hu H. 16-Morpholino quaternary ammonium steroidal derivatives as neuromuscular blocking agents: synthesis, biological evaluation and in silico probe of ligand-receptor interaction.
Eur. J. Med. Chem,2012,56:332-347
|
CSCD被引
1
次
|
|
|
|
4.
Pento J T. Rocuronium bromide.
Drugs Future,1994,19:841
|
CSCD被引
1
次
|
|
|
|
5.
Lee C. Conformation, action, and mechanism of action of neuromuscular blocking muscle relaxants.
Pharmacol. Ther,2003,98:143-169
|
CSCD被引
3
次
|
|
|
|
6.
Zlotos D P. Recent advances in neuromuscular blocking agents.
Mini Rev. Med. Chem,2005,5:595-606
|
CSCD被引
2
次
|
|
|
|
7.
Moore E W. The new neuromuscular blocking agents: do they offer any advantages.
Br. J. Anaesth,2001,87:912-925
|
CSCD被引
5
次
|
|
|
|
8.
Chavez F. Sulfuric acid adsorbed on silica gel. A multipurpose acid catalyst.
Synth. Commun,1994,24:2325-2339
|
CSCD被引
5
次
|
|
|
|
9.
Hu H. 3,16-Bisquaternaryammonium steroid derivatives as neuromuscular blocking agents: synthesis and biological evaluation.
Steroids,2015,996:103-114
|
CSCD被引
2
次
|
|
|
|
10.
Mendez J A.
Processes for the synthesis of rocuronium bromide, U.S. Patent US20070117975,2007
|
CSCD被引
1
次
|
|
|
|
11.
Adar E.
Processes for the preparation of rocuronium bromide and intermediates thereof, U.S. Patent US20050159398,2005
|
CSCD被引
1
次
|
|
|
|
12.
Sleigh T.
Novel 2b-morpholino-androstane derivatives, U.S. Patent US4894369,1990
|
CSCD被引
1
次
|
|
|
|
13.
Mendez J A.
Process for the synthesis of rocuronium bromide, WIPO Patent WO2007033348A3,2007
|
CSCD被引
1
次
|
|
|
|
14.
Nadamuni G.
Process for the preparation of rocuronium bromide and intermediate thereof, WIPO Patent WO2009016648A,2009
|
CSCD被引
1
次
|
|
|
|
15.
Jia J. Study on the synthesis and technology of rocuronium bromide.
Chem. Res. Appl,2013,25:1417-1421
|
CSCD被引
1
次
|
|
|
|
16.
Wang Y L. First synthesis of 22-oxachenodeoxycholic acid analogue.
Steroids,2016,110:70-76
|
CSCD被引
1
次
|
|
|
|
17.
Yu Y G. A simple and convenient synthetic route to Ulipristal acetate.
Steroids,2013,78:1293-1297
|
CSCD被引
2
次
|
|
|
|
18.
Cheng X. A new and efficient method for the synthesis of Ulipristal acetate.
Steroids,2014,84:78-83
|
CSCD被引
1
次
|
|
|
|
19.
Zhao Y. First synthesis and characterization for the stereoisomers of Ulipristal acetate.
Steroids,2015,95:7-16
|
CSCD被引
1
次
|
|
|
|
20.
Qian M. Neurosteroid analogues. 18. Structure-activity studies of ent-steroid potentiators of g-aminobutyric acid type A receptors and comparison of their activities with those of alphaxalone and allopregnanolone.
J. Med. Chem,2014,57:171-190
|
CSCD被引
1
次
|
|
|
|
|